Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
43,56 USD | +1,78 % | -6,92 % | +8,22 % |
13/05 | SOLENO THERAPEUTICS, INC. : Oppenheimer maintient sa recommandation à l'achat | ZM |
10/05 | SOLENO THERAPEUTICS, INC. : Opinion positive de Baird | ZM |
Métier
Nombre d'employés: 33
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Anish Bhatnagar
CEO | Chief Executive Officer | 56 | 01/01/06 |
James Mackaness
DFI | Director of Finance/CFO | 60 | 14/11/19 |
Ernest Mario
CHM | Chairman | 85 | 03/08/07 |
Kristen Yen
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/01/06 |
Charles Horn
PRN | Corporate Officer/Principal | - | 01/01/22 |
Corporate Officer/Principal | - | 24/01 | |
Lauren Budesheim
HRO | Human Resources Officer | - | 24/01 |
Patricia Hirano
LAW | General Counsel | 58 | 01/04/17 |
Neil M. Cowen
PRN | Corporate Officer/Principal | - | 01/03/17 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ernest Mario
CHM | Chairman | 85 | 03/08/07 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 26/04/19 |
Bill Harris
BRD | Director/Board Member | 65 | 02/06/14 |
Anish Bhatnagar
CEO | Chief Executive Officer | 56 | 01/01/06 |
Andrew Sinclair
BRD | Director/Board Member | 52 | 21/12/18 |
Birgitte Volck
BRD | Director/Board Member | 61 | 10/06/19 |
Matthew Pauls
BRD | Director/Board Member | 53 | 15/08/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 34 678 159 | 31 162 511 ( 89,86 %) | 0 | 89,86 % |
Coordonnées société
Soleno Therapeutics, Inc.
203 Redwood Shores Parkway Suite 500
94065, Redwood City
+650 213 8444
http://www.soleno.lifeSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+8,22 % | 1,56 Md | |
+4,26 % | 111 Md | |
+11,50 % | 105 Md | |
-13,01 % | 22,34 Md | |
-3,70 % | 21,93 Md | |
-6,03 % | 18,59 Md | |
-35,21 % | 18,12 Md | |
-10,26 % | 16,96 Md | |
+3,15 % | 13,7 Md | |
+37,09 % | 12,45 Md |
- Bourse
- Actions
- Action SLNO
- Société Soleno Therapeutics, Inc.